These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34600799)

  • 1. Human Papillomavirus Vaccination as an Adjuvant Therapy for Recurrent Respiratory Papillomatosis: Additional Case Series.
    Matsuzaki H; Makiyama K; Hasegawa H; Asai R; Morita M; Oshima T
    J Voice; 2024 Jan; 38(1):204-209. PubMed ID: 34600799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
    Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
    Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis.
    Ponduri A; Azmy MC; Axler E; Lin J; Schwartz R; Chirilă M; Dikkers FG; Yang CJ; Mehta V; Gangar M
    Laryngoscope; 2023 Sep; 133(9):2046-2054. PubMed ID: 36651338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
    Smahelova J; Hamsikova E; Ludvikova V; Vydrova J; Traboulsi J; Vencalek O; Lukeš P; Tachezy R
    JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):654-661. PubMed ID: 35653138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic use of the HPV vaccine in Recurrent Respiratory Papillomatosis: A case report.
    Sullivan C; Curtis S; Mouzakes J
    Int J Pediatr Otorhinolaryngol; 2017 Feb; 93():103-106. PubMed ID: 28109479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
    Yiu Y; Fayson S; Smith H; Matrka L
    Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Use of the Human Papillomavirus Vaccine on Recurrent Respiratory Papillomatosis: A Systematic Review and Meta-Analysis.
    Rosenberg T; Philipsen BB; Mehlum CS; Dyrvig AK; Wehberg S; Chirilǎ M; Godballe C
    J Infect Dis; 2019 Mar; 219(7):1016-1025. PubMed ID: 30358875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Human Papillomavirus Vaccination in Recurrent Respiratory Papilloma Patients Older than 45.
    Ivancic R; Freeman T; de Silva B; Forrest A; Kim B; Matrka L
    Laryngoscope; 2024 Jul; 134(7):3226-3229. PubMed ID: 38401115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.
    Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L
    Clin Exp Immunol; 2020 Feb; 199(2):131-142. PubMed ID: 31628850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis.
    Tjon Pian Gi RE; San Giorgi MR; Pawlita M; Michel A; van Hemel BM; Schuuring EM; van den Heuvel ER; van der Laan BF; Dikkers FG
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3231-6. PubMed ID: 27188508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.
    Nyirjesy S; Osmundson P; Matrka L
    J Voice; 2022 Jul; 36(4):587.e21-587.e25. PubMed ID: 32891477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases.
    Diakite I; Nguyen S; Sabale U; Pavelyev A; Saxena K; Tajik AA; Wang W; Palmer C
    J Med Econ; 2023; 26(1):1085-1098. PubMed ID: 37608730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus (HPV) vaccination is associated with reduced number of surgical treatments, an observational study on recurrent respiratory papillomatosis in Northern Sweden.
    Schindele A; Al-Sabtti S; Olofsson K
    Acta Otolaryngol; 2024 Jan; 144(1):71-75. PubMed ID: 38484282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research status of human papillomavirus vaccine for prevention and treatment of respiratory papillomatosis].
    Pan XF; Wang J; Xiao Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):189-192. PubMed ID: 30808153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intersurgical interval increased with use of quadrivalent human papillomavirus vaccine (Gardasil) in a pediatric patient with recurrent respiratory papillomatosis: A case report.
    Baumanis MM; Elmaraghy CA
    Int J Pediatr Otorhinolaryngol; 2016 Dec; 91():166-169. PubMed ID: 27863633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent respiratory papillomatosis: indication for HPV vaccination?].
    Pawlita M; Gissmann L
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S100-2. PubMed ID: 19353471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.
    Chirilă M; Bolboacă SD
    Eur Arch Otorhinolaryngol; 2014 May; 271(5):1135-42. PubMed ID: 24121781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
    Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
    Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of combined approach to recurrent respiratory papillomatosis (RRP).
    Aga A; Bekteshi E; Ajasllari G; Kosta A; Vajushi E; Kortoci R; Filauro M; Muka T; Peretti G
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3693-3700. PubMed ID: 38637412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV vaccination as preventive approach for recurrent respiratory papillomatosis - a 22-year retrospective clinical analysis.
    Mauz PS; Schäfer FA; Iftner T; Gonser P
    BMC Infect Dis; 2018 Jul; 18(1):343. PubMed ID: 30041619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.